Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
about
Doxorubicin cardiomyopathyThermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxideChemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative StressRecombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicinCombined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats.Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity.Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicity.The role of iron and iron chelators in anthracycline cardiotoxicity.Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.Changes in cholinesterase activities after daunorubicin administration to rabbits.Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity.Cardiac DT-diaphorase contributes to the detoxification system against doxorubicin-induced positive inotropic effects in guinea-pig isolated atria.Glutamine affects glutathione recycling enzymes in a DMBA-induced breast cancer model.Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after Doxorubicin treatment in rats.The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.
P2860
Q24606920-453D24A1-DA09-4458-B4B6-5880EFD84B4AQ24614185-CD37564D-7050-4733-856F-4A92334DCAF2Q26780547-AA6481EF-A835-4DDB-966C-F778449C4A93Q36363611-B76339F7-4206-4D4E-9441-E080AC63617EQ38709285-4DA2C039-BE25-43F6-8EC1-01284B5C2DA7Q39064310-99426ECE-3A8D-40A6-834A-F1FCF7086934Q39700191-87257770-57C5-4944-9F19-D3BA1958FAE3Q40790446-C5194170-CCFE-4F54-B4C3-565238A17EEEQ42552201-F7877DE0-C5A2-4412-98E3-2C3464AD9A33Q42552667-75664793-7492-4C0F-97A7-875202269B8CQ43273839-AD4FFB20-C412-4FDA-88A3-6F034996A446Q45230127-4DF5784E-06E5-4023-BA23-1AF791408667Q46515430-A8B4B094-1A74-40A4-8554-1DAFFC384B81Q46626254-83F31686-AD09-47E7-BF67-E9849FEABDA7Q46921449-67EE1983-173E-4E54-A6C1-66F219E56EBCQ51125585-93F963A2-C521-4716-82C1-EFEBFF2D22E7
P2860
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@en
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@nl
type
label
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@en
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@nl
prefLabel
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@en
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@nl
P2093
P1476
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.
@en
P2093
A M Benson
C A Hatwig
J S Stanley
P304
P356
10.1016/0006-2952(92)90250-M
P407
P577
1992-02-01T00:00:00Z